Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!

Range Low Price High Price Comment
30 days $68.49 $68.49 Friday, 27th Jan 2023 GBT stock ended at $68.49. During the day the stock fluctuated 0% from a day low at $68.49 to a day high of $68.49.
90 days $68.49 $68.49
52 weeks $21.65 $73.02

Historical GLOBAL BLOOD THERAPEUTICS prices

Date Open High Low Close Volume
Apr 28, 2016 $20.95 $22.15 $20.26 $21.00 289 707
Apr 27, 2016 $20.32 $21.38 $19.99 $21.04 191 689
Apr 26, 2016 $21.30 $21.30 $20.19 $20.28 151 812
Apr 25, 2016 $21.32 $21.86 $20.94 $21.24 140 376
Apr 22, 2016 $21.21 $21.61 $20.55 $21.29 146 846
Apr 21, 2016 $20.76 $21.49 $20.00 $21.26 294 327
Apr 20, 2016 $21.13 $21.60 $20.25 $20.79 506 323
Apr 19, 2016 $21.07 $21.29 $19.82 $19.98 220 167
Apr 18, 2016 $21.12 $21.38 $20.75 $21.11 153 035
Apr 15, 2016 $20.46 $21.53 $20.13 $21.36 148 488
Apr 14, 2016 $20.54 $20.84 $20.02 $20.51 224 153
Apr 13, 2016 $19.67 $20.60 $19.39 $20.52 126 633
Apr 12, 2016 $19.07 $19.66 $18.85 $19.43 161 352
Apr 11, 2016 $19.21 $19.77 $18.52 $19.06 183 468
Apr 08, 2016 $19.64 $19.85 $18.50 $19.00 139 795
Apr 07, 2016 $20.39 $21.25 $18.90 $19.25 403 491
Apr 06, 2016 $18.78 $20.93 $18.39 $20.76 372 811
Apr 05, 2016 $17.88 $19.37 $17.69 $18.68 216 970
Apr 04, 2016 $16.20 $18.62 $15.43 $18.14 530 822
Apr 01, 2016 $15.57 $16.31 $15.10 $16.13 220 123
Mar 31, 2016 $14.93 $16.41 $14.78 $15.86 306 730
Mar 30, 2016 $14.71 $15.16 $14.47 $14.95 115 537
Mar 29, 2016 $12.94 $14.85 $12.24 $14.54 299 900
Mar 28, 2016 $14.23 $14.64 $12.79 $12.99 341 400
Mar 24, 2016 $14.85 $14.89 $13.86 $14.06 199 600
Click to get the best stock tips daily for free!

About GLOBAL BLOOD THERAPEUTICS

GLOBAL BLOOD THERAPEUTICS Global Blood Therapeutics, Inc., a biopharmaceutical company, engages in the discovery, development, and delivery of treatments for underserved patient communities with sickle cell disease (SCD). The company offers Oxbryta tablets, an oral, once-daily therapy for SCD. It also evaluates the safety and pharmacokinetics of single and multiple doses of Oxbryta in a Phase II a clinical trial of adolescent and pediatric patients with SCD. In addition, ... GBT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT